Skip to main content
SpringerLink
Log in

Comorbidité et particularités des complications des tumeurs endocrines sécrétrices de sérotonine

  • Chapter
Tumeurs endocrines thoraciques et digestives

  • 323 Accesses

Abstrait

Les tumeurs endocrines digestives notamment iléales sont, dans la plupart des cas, lentement évolutives et la survie des patients prolongée. En l’absence de possibilité d’exérèse chirurgicale radicale, le traitement est cependant seulement palliatif dans la grande majorité des cas avec une évolution métastatique lentement progressive, mais irréversible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Makridis C, Ekbom A, Bring J et al. (1997) Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 122: 1075–82

    Article  PubMed  CAS  Google Scholar 

  2. Lundin L, Norheim I, Landelius J et al. (1988) Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 77: 264–9

    PubMed  CAS  Google Scholar 

  3. Kulke MH, Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340: 858–68

    Article  PubMed  CAS  Google Scholar 

  4. Jian B, Xu J, Connolly J et al. (2002) Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 161: 2111–21

    PubMed  CAS  Google Scholar 

  5. Xu J, Jian B, Chu R et al. (2002) Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 161: 2209–18

    PubMed  CAS  Google Scholar 

  6. Mitry E, Mansencal N, Digne F et al. (2003) Cardiopathie valvulaire gauche des tumeurs endocrines du tube digestif: suivi échocardiographique à un an. Gastroenterol Clin Biol 27(HS1): A162

    Google Scholar 

  7. Moller JE, Connolly HM, Rubin J et al. (2003) Factors associated with progression of carcinoid heart disease. N Engl J Med 348: 1005–15

    Article  PubMed  Google Scholar 

  8. Connolly HM, Nishimura RA, Smith HC et al. (1995) Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 25: 410–6

    Article  PubMed  CAS  Google Scholar 

  9. Hoffmann J, Grimm W, Menz V et al. (1999) Heart rate variability in carcinoid heart disease. Am J Cardiol 83:128–31, A9

    Article  PubMed  CAS  Google Scholar 

  10. Kucuk O, Noskin G, Petersen K et al. (1988) Lower extremity vasospasm associated with ischemic neuropathy, dermal fibrosis, and digital gangrene in a patient with carcinoid syndrome. Cancer 62: 1026–9

    Article  PubMed  CAS  Google Scholar 

  11. Strobbe L, D’Hondt E, Ramboer C et al. (1994) Ileal carcinoid tumors and intestinal ischemia. Hepatogastroenterology 41: 499–502

    PubMed  CAS  Google Scholar 

  12. Eckhauser FE, Argenta LC, Strodel WE et al. (1981) Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 90: 720–8

    PubMed  CAS  Google Scholar 

  13. Russo S, Boon JC, Kema IP et al. (2004) Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation. Psychosom Med 66: 422–5

    Article  PubMed  Google Scholar 

  14. Swain CP, Tavill AS, Neale G (1976) Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology 71: 484–9

    PubMed  CAS  Google Scholar 

  15. Bax NDS, Woods HF, Batchelor A et al. (1996) Clinical manifestations of carcinoid disease. World J Surgery 20: 142–6

    Article  CAS  Google Scholar 

  16. Van der Horst-Schrivers AN, Wymenga AN, Links TP et al. (2004) Complications of midgut carcinoid tumors and carcinoid syndrome. Neuroendocrinology 80Suppl 1: 28–32

    Article  PubMed  Google Scholar 

  17. Yu F, Venzon DJ, Serrano J et al. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long standing Zollinger-Ellison syndrome. J Clin Oncol 17: 615–30

    PubMed  CAS  Google Scholar 

  18. Ohrvall U, Eriksson B, Juhlin C et al. (2000) Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 24: 1402–8

    Article  PubMed  CAS  Google Scholar 

  19. Zinelabidine Y, Chatti N, Jemni L et al. (1989) Tumeur carcinoide de l’iléon associée à une fibrose rétropéritonéale et une atteinte cardiaque droite. Press Med 18: 1847

    CAS  Google Scholar 

  20. Dev S, al-Dujaily S, Subbuswamy SG (1999) A case of ureteric obstruction, retroperitoneal fibrosis, and carcinoid tumour. Postgrad Med J 75: 38–40

    PubMed  CAS  Google Scholar 

  21. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97: 934–9

    Article  PubMed  Google Scholar 

  22. Westergaard T, Frisch M, Melbye M (1995) Carcinoid tumors in Denmark 1978–1989 and the risk of subsequent cancers. A population-based study. Cancer 76: 106–9

    Article  PubMed  CAS  Google Scholar 

  23. Levi F, Te VC, Randimbison L, Rindi G (2000) Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–1997. Br J Cancer 83: 952–5

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastro-entérologie et oncologie digestive, CHU Ambroise Paré, 9, avenue Charles de Gaulle, 92100, Boulogne

    E. Mitry

Authors
  1. E. Mitry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Mitry, E. (2008). Comorbidité et particularités des complications des tumeurs endocrines sécrétrices de sérotonine. In: Tumeurs endocrines thoraciques et digestives. Springer, Paris. https://doi.org/10.1007/978-2-287-35574-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-35574-5_6

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-35573-8

  • Online ISBN: 978-2-287-35574-5

Publish with us

Policies and ethics

Search

Navigation